Vela Laboratories and Evercyte Announce Cooperation to Provide Immortalized Cell Lines for Biosimilar Characterization
VelaLabs, a provider of analytical services to the global biopharmaceutical industry, and Evercyte, a producer of standardized, relevant cell systems, today (Sept. 3) announced that they have entered into a cooperation to commercialize immortalized target cells for the characterization of biosimilars in a GMP environment.